Efficacy of MSC for steroid-refractory acute GVHD associates with MSC donor age and a defined molecular profile

Affiliations

• ¹ Department of Hematology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
• ² Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
• ³ Cell Therapy Facility, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
• ⁴ Pediatric Blood and Marrow Transplant Program Prinses Maxima Centre for Pediatric Oncology, Utrecht, the Netherlands.
• ⁵ Center for Molecular Medicine and Regenerative Medicine Center UMC Utrecht, Utrecht University, Utrecht, the Netherlands.
• ⁶ Department of Hematology, UMC Groningen, Groningen, the Netherlands.
• ⁷ Department of Hematology, Amsterdam University Medical Centers, loc. VUmc Amsterdam, Amsterdam, the Netherlands.
• ⁸ Department of Hematology, Erasmus Medical Center Rotterdam, Rotterdam, the Netherlands.
• ⁹ Department of Hematology, Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands.
• ¹⁰ Department of Internal Medicine, Isala klinieken Zwolle, Zwolle, the Netherlands.
• ¹¹ Department of Hematology, Academic Medical Center Amsterdam, Amsterdam, the Netherlands.
• ¹² Department of Hematology, Princess Maxima Centrum, Utrecht, the Netherlands.
• ¹³ Department of Pediatrics, Stem Cell Transplant and Cellular Therapies Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
• ¹⁴ Department of Hematology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands. J.H.E.Kuball@umcutrecht.nl.
• ¹⁵ Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands. J.H.E.Kuball@umcutrecht.nl.